Skip to main content
. 2021 Nov 18;15:1318. doi: 10.3332/ecancer.2021.1318

Table 2. Adverse event details in both arms. The numbers with percentages in brackets are depicted.

Adverse event Diclofenac arm (n = 66) Tramadol arm (n = 62) p value for any grade events p value for grade 3 & above events
Any grade Grade 3–5 Any grade Grade 3–5
Mucositis 66 (100) 23 (34.8) 62 (100) 17 (27.4) - 0.47
Dysphagia 60 (90.9) 20 (30.3) 56 (90.3) 12 (19.4) 1 0.22
Weight loss 39 (59.1) 1 (1.5) 39 (62.9) - 0.72 1
Nausea 26 (39.4) 2 (3) 20 (32.3) 2 (3.2) 0.47 1
Vomiting 17 (25.8) - 18 (29) 2 (3.2) 0.7 0.23
Constipation 7 (11.3) - 13 (19.7) - 0.23 -
Rise in creatinine 7 (10.6) - 3 (4.8) - 0.33 -
Hyponatraemia 60 (90.9) 17 (25.8) 54 (87.1) 17 (27.4) 0.58 0.84
Hypokalaemia 4 (6.1) 1 (1.5) 8 (12.9) 3 (4.8) 0.23 0.35
Hypomagnesaemia 22 (33.3) - 28 (45.2) 1 (1.6) 0.21 0.48
SGOT rise 9 (13.6) 1 (1.5) 11 (17.7) 1 (1.6) 0.63 1
SGPT rise 12 (18.2) 1 (1.5) 14 (22.6) 1 (1.6) 0.66 1
Anaemia 53 (80.3) 3 (4.5) 54 (87.1) - 0.35 0.25
Neutropenia 15 (22.7) 6 (9.1) 21 (33.9) 6 (9.7) 0.17 1
Thrombocytopenia 14 (21.2) 2 (3) 15 (24.2) 1 (1.6) 0.83 1

SGOT, Serum glutamic-oxaloacetic transaminase; SGPT, Serum glutamic pyruvic transaminase